We are live on ! Find out more
BSTC

BioSpecifics Technologies Corp.
BSTC

Delisted

BSTC was delisted on the 1st of December, 2020.

Back to rankings

114 hedge funds and large institutions have $259M invested in BioSpecifics Technologies Corp. in 2019 Q2 according to their latest regulatory filings, with 16 funds opening new positions, 51 increasing their positions, 34 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

50% more repeat investments, than reductions

Existing positions increased: 51 | Existing positions reduced: 34

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

0% more first-time investments, than exits

New positions opened: 16 | Existing positions closed: 16

2% less capital invested

Capital invested by funds: $264M → $259M (-$5.37M)

3% less funds holding

Funds holding: 117 → 114 (-3)

Holders
114
Holders Change
-3
Holders Change %
-2.56%
% of All Funds
2.48%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
16
Increased
51
Reduced
34
Closed
16
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
N
Nuveen
North Carolina
+$4.49M
2
Millennium Management
Millennium Management
New York
+$4.11M
3
AQR Capital Management
AQR Capital Management
Connecticut
+$3.28M
4
RC
Roubaix Capital
Colorado
+$2.84M
5
Allianz Asset Management
Allianz Asset Management
Germany
+$2.66M

Top Sellers

Rank Fund Capital Flow
1
Acadian Asset Management
Acadian Asset Management
Massachusetts
-$9.02M
2
ECP
Elk Creek Partners
Colorado
-$4.61M
3
JAM
JW Asset Management
Florida
-$4.59M
4
EGI
EAM Global Investors
California
-$1.42M
5
EI
EAM Investors
California
-$1.1M
Name Holding Trade Value Shares
Change 		Change in
Stake
Renaissance Technologies
1
Renaissance Technologies
New York
$33.6M -$588K -9,340 -2%
BlackRock
2
BlackRock
New York
$25.6M +$1.45M +23,007 +6%
RHJA
3
Rice Hall James & Associates
California
$21.2M +$2.42M +38,483 +12%
Dimensional Fund Advisors
4
Dimensional Fund Advisors
Texas
$18.6M +$467K +7,428 +2%
Vanguard Group
5
Vanguard Group
Pennsylvania
$16.6M +$83.1K +1,320 +0.5%
Goldman Sachs
6
Goldman Sachs
New York
$10.3M +$568K +9,027 +6%
State Street
7
State Street
Massachusetts
$7.46M +$447K +7,101 +6%
Allianz Asset Management
8
Allianz Asset Management
Germany
$6.81M +$2.66M +42,342 +59%
AQR Capital Management
9
AQR Capital Management
Connecticut
$6.79M +$3.28M +52,147 +85%
Geode Capital Management
10
Geode Capital Management
Massachusetts
$5.91M +$1.07M +16,946 +21%
Northern Trust
11
Northern Trust
Illinois
$5.63M +$80.4K +1,278 +1%
Wells Fargo
12
Wells Fargo
California
$5.48M +$1.31M +20,830 +29%
AL
13
AJO LP
Pennsylvania
$5.06M +$133K +2,114 +3%
Millennium Management
14
Millennium Management
New York
$5.05M +$4.11M +65,237 +338%
TAM
15
THB Asset Management
Connecticut
$5M -$235K -3,731 -4%
MCM
16
Matarin Capital Management
New York
$4.68M +$527K +8,371 +12%
N
17
Nuveen
North Carolina
$4.26M +$4.49M +71,283 New
Prudential Financial
18
Prudential Financial
New Jersey
$3.94M -$237K -3,770 -5%
Bank of New York Mellon
19
Bank of New York Mellon
New York
$3.82M +$191K +3,028 +5%
EAM
20
Eagle Asset Management
Florida
$3.58M -$391K -6,213 -9%
RC
21
Roubaix Capital
Colorado
$2.69M +$2.84M +45,142 New
Charles Schwab
22
Charles Schwab
California
$2.52M +$87.4K +1,389 +3%
American Century Companies
23
American Century Companies
Missouri
$2.49M +$119K +1,895 +5%
RA
24
Royce & Associates
New York
$2.44M +$2.9K +46 +0.1%
Man Group
25
Man Group
United Kingdom
$2.35M +$335K +5,323 +16%
1
2 3 4 5

BSTC Hedge Fund Activity: Q2 2019 in Review

114 of the 4,604 institutional investors tracked by Wall St. Rank reported a position in BioSpecifics Technologies Corp. (BSTC) for Q2 2019, worth a combined $259M — down 2% from $264M a quarter earlier.

Fund positioning in BSTC was balanced in Q2 2019: 16 funds opened new positions, 16 closed out, 51 added to existing stakes and 34 trimmed.

The largest buyer was Nuveen, opening a new position worth an estimated $4.49M. The largest seller was Acadian Asset Management, exiting entirely with an estimated $9.02M sold.

  • 114 institutional investors held BioSpecifics Technologies Corp. (BSTC) as of Q2 2019, down from 117 in Q1 2019.
  • Funds reported $259M of BioSpecifics Technologies Corp. stock for Q2 2019, down 2% quarter-over-quarter.
  • 16 funds opened new BioSpecifics Technologies Corp. positions in Q2 2019 and 16 closed out, a net change of 0 holders.
  • The largest BioSpecifics Technologies Corp. buyer in Q2 2019 was Nuveen, an estimated $4.49M added.
  • The largest BioSpecifics Technologies Corp. seller in Q2 2019 was Acadian Asset Management, an estimated $9.02M sold.

Based on aggregated 13F filings for Q2 2019.